• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Etomidate

Etomidate

Product ID E7758
Cas No. 33125-97-2
Purity ≥99%
Product Unit SizeCostQuantityStock
10 mg $127.70 In stock
25 mg $255.30 In stock
100 mg $728.80 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Etomidate activates GABA-A receptors, displaying neuromodulatory, anesthetic, and amnestic activities. Etomidate prevents neurotransmitter release in neurons by inhibiting presynaptic excitatory synaptic transmission in a SNARE-dependent manner. Etomidate also attenuates acetylcholine-induced relaxation in aortic endothelial tissue, but does not display significant cardiovascular side effects when used clinically. In animal models, etomidate impairs memory performance in several tasks.

Product Info

Cas No.

33125-97-2

Purity

≥99%

Formula

C14H16N2O2

Formula Wt.

244.29

IUPAC Name

ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate

Synonym

Amidate

Solubility

DMSO: >10 mg/mL

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

E7758 MSDS PDF

Info Sheet

E7758 Info Sheet PDF

References

Herring BE, McMillan K, Pike CM, et al. Etomidate and propofol inhibit the neurotransmitter release machinery at different sites. J Physiol. 2011 Mar 1;589(Pt 5):1103-15. Erratum in: J Physiol. 2011 Sep 15;589(Pt 18):4633. PMID: 21173083.

Martin LJ, Oh GH, Orser BA. Etomidate targets alpha5 gamma-aminobutyric acid subtype A receptors to regulate synaptic plasticity and memory blockade. Anesthesiology. 2009 Nov;111(5):1025-35. PMID: 19809285.

Sohn JT, Kim HJ, Cho HC, et al. Effect of etomidate on endothelium-dependent relaxation induced by acetylcholine in rat aorta. Anaesth Intensive Care. 2004 Aug;32(4):476-81. PMID: 15682522.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P465822

    Pluripotin

    Dual kinase and GTPase inhibitor.

    ≥98%
  • E5202

    Enalapril

    ACE inhibitor.

    ≥98%
  • O610291

    Ophiobolin A

    Tetracyclic sesterpenoid phytotoxin.

    ≥98%
  • B5609

    Boc-GRR-AMC

    Peptide, protease substrate.

    ≥98%
  • D3322

    Diflunisal

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • A040068

    AB-680

    CD73 inhibitor

    ≥98%
  • T1010

    7-Acetyl Paclitaxel

    Synthesis impurity

    ≥98%
  • C0145

    Calcitriol

    Active form of vitamin D, regulates dietary Ca2...

    ≥97%
  • A5235

    Amitriptyline Hydrochloride

    FIASMA, σ1, RyR2, TrkA/B agonist; SERT, NET in...

    ≥98%
  • N5072

    NMS-1286937

    PLK1 inhibitor.

    ≥98%
  • T3097

    Thymosin α-1 Acetate

    Endogenous peptide, involved in hormone regulat...

    ≥95%
  • A2501

    AG-1517

    EGFR inhibitor.

    ≥98%
  • I5203

    Inauhzin

    p53 activator, IMPDH and SIRT1 inhibitor.

    ≥98%
  • T1679

    Tetracycline Hydrochloride

    Polyketide; protein translation inhibitor, mamm...

    ≥95%
  • V1745

    Veliparib

    PARP inhibitor.

    ≥99%
  • A2532

    AGI-6780

    Isocitrate dehydrogenase inhibitor.

    ≥98%
  • U698576

    Urolithin B

    Ellagic acid derivative produced by gut microfl...

    ≥99%
  • N1868

    Neratinib

    EGFR inhibitor.

    ≥98%
  • P327212

    Pifithrin-α-cyclic Hydrobromide

    p53 inhibitor

    ≥98%
  • C9610

    D-Cycloserine

    NMDA partial agonist, D-Ala-D-Ala ligase inhibi...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only